Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
复制标题
DOI:
10.1186/s13195-017-0328-9
复制
发表时间:
2017-12-29
期刊:
影响因子:
--
通讯作者:
Vos SJB
中科院分区:
文献类型:
--
作者:
Bos I;Verhey FR;Ramakers IHGB;Jacobs HIL;Soininen H;Freund-Levi Y;Hampel H;Tsolaki M;Wallin ÅK;van Buchem MA;Oleksik A;Verbeek MM;Olde Rikkert M;van der Flier WM;Scheltens P;Aalten P;Visser PJ;Vos SJB
Cerebrovascular disease (CVD) and amyloid-β (Aβ) often coexist, but their influence on neurodegeneration and cognition in predementia stages remains unclear. We investigated the association between CVD and Aβ on neurodegenerative markers and cognition in patients without dementia. We included 271 memory clinic patients with subjective or objective cognitive deficits but without dementia from the BioBank Alzheimer Center Limburg cohort (n = 99) and the LeARN (n = 50) and DESCRIPA (n = 122) multicenter studies. CSF Aβ1–42 and white matter hyperintensities (WMH) on magnetic resonance imaging (MRI) scans were used as measures of Aβ and CVD, respectively. Individuals were classified into four groups based on the presence (+) or absence (−) of Aβ and WMH. We investigated differences in phosphorylated tau, total tau (t-tau), and medial temporal lobe atrophy (MTA) between groups using general linear models. We examined cognitive decline and progression to dementia using linear mixed models and Cox proportional hazards models. All analyses were adjusted for study and demographics. MTA and t-tau were elevated in the Aβ − WMH+, Aβ + WMH−, and Aβ + WMH+ groups. MTA was most severe in the Aβ + WMH+ group compared with the groups with a single pathology. Both WMH and Aβ were associated with cognitive decline, but having both pathologies simultaneously was not associated with faster decline. In the present study, we found an additive association of Aβ and CVD pathology with baseline MTA but not with cognitive decline. Because our findings may have implications for diagnosis and prognosis of memory clinic patients and for future scientific research, they should be validated in a larger sample with longer follow-up. The online version of this article (doi:10.1186/s13195-017-0328-9) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
1.8
作者:
Hoenig, JM;Heisey, DM
通讯作者:
Heisey, DM
DOI:
10.1136/bmj.c3666
发表时间:
2010-07-26
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Debette S;Markus HS
通讯作者:
Markus HS
影响因子:
2.6
作者:
Handels RL;Aalten P;Wolfs CA;OldeRikkert M;Scheltens P;Visser PJ;Joore MA;Severens JL;Verhey FR
通讯作者:
Verhey FR
影响因子:
2.6
作者:
Aalten, Pauline;Ramakers, Inez H. G. B.;van der Flier, Wiesje M.
通讯作者:
van der Flier, Wiesje M.
影响因子:
9.9
作者:
Lo, Raymond Y.;Jagust, William J.
通讯作者:
Jagust, William J.